Sports

FranklinWH Announces aPower S with Direct Solar Integration and Begins US Domestic Manufacturing

aPowerS offers a simple and flexible pairing for solar and storage,while FranklinWH begins manufacturinginCalifornia

MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

BUYING SQUARE Opens Experiential Brand Showroom 'VIBE TWLV' in Brooklyn

NEW YORK,Feb. 25,2025-- BUYING SQUARE,operator of the next-generation digital wholesale platform Catalog Shop,unveiled its experiential brand showroom,VIBE TWLV,in Brooklyn,New York. The 4,270-square-

Risen Achieves 30.99% Efficiency with HJT-Perovskite Tandem Solar Cells!

NINGBO,China,Feb. 26,2025-- Breaking new ground in solar innovation! Risen\'sHJT (Heterojunction Technology),when combined with aperovskitecell in a tandem structure,has achieved an impressive30.99% e

Little Artists Students from Singapore Shine at Art Capital 2025 at Grand Palais, Paris

PARIS,Feb. 25,2025-- Little Artists Art Studio,is proud to share the historic debut of their young and rising talents at the prestigious Art Capital Paris: Le Salon des Artistes Français at the

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

Pudu Robotics Enhances Cleaning Efficiency at Ryugujo Spa Hotel Mikazuki Ryugutei with the Introduction of PUDU SH1

SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

Home Previous 7 8 9 10 11 12 13 Next Tail

10 Items Per Page (Page 10 / 83) Total 826 Items